bpc-157 news and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded Peptides like BPC-157 and TB-500
Description
Additionally, they were able to show that activation of mast cells in osteoarthritis is through IgE/FcRI
Cardiac protection: TB-500 shows particular promise for heart tissue repair, with studies demonstrating improved outcomes after cardiac injury
Regulatory status further limits clinical use, since BPC-157 is not approved for medical treatment and available data remains largely experimental
Highland Longevity is different
Methods of administration for BPC-157 in research settings include subcutaneous, intramuscular, and oral forms
FDA lacks important information regarding any safety issues raised by KPV, including whether it would cause harm if administered to humans.18 In other words, there have been no dedicated safety studies on KPV, so its status as a safe or unsafe therapy is up in the air
